Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Veracyte, Inc. | 12V | Nov 14, 2024 | 37.20 | +4.49 |
VERALLIA. | 1VRA | Nov 14, 2024 | 26.12 | +0.31 |
Veralto | RZ2 | Nov 14, 2024 | 99.12 | -0.87 |
VERANO HOLDINGS (SUB.VT.) | 76U0 | Nov 14, 2024 | 2.86 | 0.00 |
Verastem | 2VSA | Nov 14, 2024 | 3.82 | -2.05 |
Verbio SE | VBK | Nov 14, 2024 | 12.23 | +1.58 |
Verbrec Limited | 47L | Nov 14, 2024 | 0.06 | -0.81 |
Verbund AG | OEWA | Nov 14, 2024 | 74.65 | +6.57 |
Verbund AG | OEW | Nov 14, 2024 | 13.90 | +0.72 |
Vercom S.A. | 14W | Nov 14, 2024 | 27.10 | +0.37 |
Veren | 0160 | Nov 14, 2024 | 4.75 | +2.02 |
Vergnet | VRQ | Nov 14, 2024 | 0.00 | +10.00 |
Verianos Real Estate AG | VROS | Nov 14, 2024 | 0.00 | 0.00 |
Vericel Corporation | ATQP | Nov 14, 2024 | 52.00 | 0.00 |
Verici Dx Plc | 63V | Nov 14, 2024 | 0.03 | 0.00 |
VerifyMe, Inc. | LT1B | Nov 14, 2024 | 0.90 | -8.67 |
Verimatrix | I3Q | Nov 14, 2024 | 0.34 | +0.30 |
Verint Systems Inc. | VTY | Nov 14, 2024 | 23.00 | -4.17 |
VeriSign, Inc. | VRS | Nov 14, 2024 | 173.55 | +1.14 |
Verisk Analytics, Inc. | VA7A | Nov 14, 2024 | 274.60 | +1.67 |
Veritex Holdings, Inc. | 47Y | Nov 14, 2024 | 28.20 | -0.70 |
Veritone, Inc. | VEK | Nov 14, 2024 | 2.87 | +6.94 |
VERIZON COMMUNICAT. CDR | BACB | Nov 14, 2024 | 11.90 | +1.71 |
Verizon Communications Inc. | BAC | Nov 14, 2024 | 39.23 | +1.65 |
Verkkokauppa.com | 15V | Nov 14, 2024 | 1.43 | +1.27 |
Vermilion Energy Inc. Common (Canada) | CVZ | Nov 14, 2024 | 8.78 | -0.39 |
Verona Pharma plc - American Depositary Shares | I9SA | Nov 14, 2024 | 34.00 | -5.03 |
Verra Mobility Corp | 0YK | Nov 14, 2024 | 22.00 | 0.00 |
Verrica Pharmaceuticals Inc. | 1NE | Nov 14, 2024 | 0.79 | -7.19 |
VersaBank. | VEW | Nov 14, 2024 | 15.50 | -1.27 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.